Health Care: Drugs

Pharmacyclics Inc (PCYC: NASDAQ)

$123.42 -1.33 | -1.07%
07/30/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 123.42
52 Week High 154.89
52 Week Low 82.51
Avg. Daily Vol. (Mil) 1.27
Beta (3 year) 1.18
Share Related Items
Mkt Cap (Mil) 9,260.45
Shares Out (Mil) 75.03
Float (Mil) 44.50
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.50
Current Ratio 8.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 69.60
Price/Sales 24.58
Price/Book 13.94
Price/Cash Flow 66.20
Per Share Data
Earnings 1.77
Sales 5.02
Book Value 8.85
Cash Flow 1.86
Business Summary
Pharmacyclics, Inc., is a biopharmaceutical company engaged in designing, developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases.
General Information
995 East Arques Avenue
Sunnyvale, CA 94085-4521
www.pharmacyclics.com
Industry : Drugs
Sector: Health Care
Employees: 484
CEO: Robert W. Duggan
Short Interest
Current Month (Mil) 6.32
Previous Month (Mil) 5.62
Short Interest Ratio (Days) 6.10
Management Effectiveness
Return on Equity 20.70
Return on Assets 17.00
Return on Investments 20.70
Profitability
Gross Margin 91.50
EBIT Margin 44.90
Profit Margin 36.40

Portfolios with PCYC

Latest PCYC Headlines from TheStreet

More Financial News for PCYC

Press Releases for PCYC

See All Press Releases

Partner Headlines for PCYC

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter